Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil.
about
Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate.Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticlesFormulation and in vitro characterization of cefpodoxime proxetil gastroretentive microballoonsIn vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.
P2860
Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Investigation of factors respo ...... ility of cefpodoxime proxetil.
@en
Investigation of factors respo ...... ility of cefpodoxime proxetil.
@nl
type
label
Investigation of factors respo ...... ility of cefpodoxime proxetil.
@en
Investigation of factors respo ...... ility of cefpodoxime proxetil.
@nl
prefLabel
Investigation of factors respo ...... ility of cefpodoxime proxetil.
@en
Investigation of factors respo ...... ility of cefpodoxime proxetil.
@nl
P2093
P1476
Investigation of factors respo ...... ility of cefpodoxime proxetil.
@en
P2093
Arvind K Bansal
Vasu Kumar Kakumanu
Vinod Arora
P304
P356
10.1016/J.IJPHARM.2006.03.004
P407
P577
2006-03-12T00:00:00Z